NIA set to build $300M ‘real world’ Alzheimer’s database
By
Alicia Lasek
Apr 06, 2023
The goal is to collect real-world data on Alzheimer’s disease and create a centralized data hub, helping to expand and speed Alzheimer’s research.
NIH highlights decade of Alzheimer’s advancements tied to small business investments
By
Alicia Lasek
Aug 11, 2021
A new paper showcases the results of 11 years of federal investment in dementia research, including advancements in care intervention, diagnostics and therapeutics.
NYC facility halves UTI rate, care costs with ‘practical’ intervention
By
Alicia Lasek
Mar 15, 2021
Gouverneur Health, a 295-bed skilled nursing facility, brought its average UTI rate to 2.13%, — lower than state and national benchmarks — and reduced its related care costs by 52% from the pre-intervention...
Clinical briefs for Friday, Dec. 9
By
Alicia Lasek
Dec 09, 2022
Next health emergency to reveal impact of patient visitor law … $11M NIH grant to support evaluation of Alzheimer’s screening tool in primary care … COVID rebound uncommon among patients treated...
Poor sleep linked to more COPD flare-ups: NIH study
By
Alicia Lasek (f3)
Jun 07, 2022
Poor sleep quality is a good predictor of whether a patient with COPD will have exacerbations, researchers say.
Clinical briefs for Tuesday, Aug. 17
By
Alicia Lasek
Aug 17, 2021
NIH: A single skills-based class relieves lower back pain … Still no mandate, but Pennsylvania wants 80% of SNF workers vaccinated by October … Federal scientists develop faster COVID-19 test … APIC...
NIH: Temperature-stable TB vaccine found safe, effective in trial
By
Alicia Lasek
Mar 07, 2023
A temperature-stable tuberculosis vaccine that lasts for months in storage is safe and effective in healthy adults, according to the results of a new trial.
NIH: ‘Good’ cholesterol may not universally predict heart disease risk
By
Alicia Lasek
Nov 28, 2022
In a study of 23,000 people, high HDL cholesterol levels were not associated with reduced cardiovascular disease risk, and low levels predicted increased heart disease in white but not Black adults.
Common autoimmune drugs reduce mortality, up clinical status in COVID-19: NIH
By
Alicia Lasek (f3)
Jun 06, 2022
Two commonly used autoimmune drugs could be used in addition to standard-of-care treatments to improve COVID-19 outcomes, the agency says.
Feds look to OTC drugs for self-treatment of mild, moderate COVID
By
Alicia Lasek
Apr 21, 2021
A large trial is set to study the potential for repurposed, over-the-counter drugs to treat mild-to-moderate COVID-19 symptoms. If found effective, the approval timeline will likely be short, according...